Janux Therapeutics Inc share price logo

Janux Therapeutics Inc

NASDAQ: JANX

Small Cap

$11.36

-0.13

(-1.17%)

as on

Janux Therapeutics Inc Stock Performance

as on November 14, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $11.16
    $11.56
    downward going graph

    1.76%

    Downside

    1.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.16
    $35.34
    downward going graph

    1.80%

    Downside

    211.09%

    Upside

    downward going graph

Janux Therapeutics Inc share price movements today

Previous Close
$11.49
Open
$11.44
Volume
481.6K
Market Cap
$703.3M
Day's Low - High
$11.16 - $11.56
52 Week Low - High
$11.16 - $35.34

Janux Therapeutics Inc Historical Returns

1 Month Return
-33.63 %
3 Month Return
-29.47 %
1 Year Return
-61.17 %
3 Year Return
+ 36.49 %
5 Year Return
-49.42 %

Janux Therapeutics Inc Stock Fundamentals & Key Indicators

Check Janux Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$703.3M

EPS (TTM)

-1.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.18

Industry PE ratio

-6.17

PEG Ratio

-2.63

EBITDA

-98.0M

Revenue (TTM)

23.3M

Profit Margin

100.00%

Return On Equity TTM

-10.68%

Janux Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Janux Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$703.3M-49.42%-7.18100.00%0.00%
Neutral$100.6B0.07%-35.1828.00%0.00%
StrongBuy$48.0BNA68.5088.39%0.00%
StrongBuy$138.7B189.72%34.9385.57%0.00%
Buy$94.7B50.70%20.4385.77%0.39%

Stock Returns calculator for Janux Therapeutics Inc Stock including INR - Dollar returns

The Janux Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Janux Therapeutics Inc investment value today

Current value as on today

₹41,162

Returns

-₹58,838

(-58.84%)

Returns from Janux Therapeutics Inc Stock

-₹61,202 (-61.2%)

Dollar Impact

₹2,365 (+2.36%)

Analyst Recommendation on Janux Therapeutics Inc Stock

Based on 7 analysts

BUY

71.43%

Buy

14.29%

Hold

14.29%

Sell

Based on 7 analysts, 71.42857142857143% of analysts recommend a 'BUY' rating for Janux Therapeutics Inc. Average target price of $33.14

Janux Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Janux Therapeutics Inc.

What analysts predicted

65.72%UPSIDE

Target Price

$33.14

Current Price

$11.36

Analyzed by

7 Analysts

High

$55

Target

$33.14

Low

$15

Janux Therapeutics Inc target price $33.14, a slight upside of 65.72% compared to current price of $11.36. According to 7 analysts rating.

Indian Investors' Interest in Janux Therapeutics Inc Stock

Search interest for Janux Therapeutics Inc Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:88% versus previous 30 day period

Janux Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
8
0
-
-
-
10
-
3
10
9
Gross Profit
8
0
-
-
-
10
-
3
10
9
Operating Income
-13
-35
-29
-34
-45
-35
-42
-34
-31
-31
EBITDA
-5
-27
-19
-22
-33
-23
-31
-23
-21
-21
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-28
-20
-23
-33
-24
-31
-24
-21
-21
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-5
-28
-20
-23
-33
-24
-31
-24
-21
-21
Net Profit Margin
94.31%
100.00%
0.00%
0.00%
0.00%
100.00%
0.00%
100.00%
100.00%
100.00%

Janux Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
3
8
8
10
10
Gross Profit
0
0
-22
7
6
8
7
Operating Income
-3
-4
-32
-67
-72
-98
-157
EBITDA
-3
-6
-32
-62
-56
-66
-111
Interest Expense
0
0
-
-
-
-
-
Depreciation
0
0
0
0
1
2
2
Income Before Tax
-4
-6
-32
-63
-58
-68
-113
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-4
-6
-32
-63
-58
-68
-113
Net Profit Margin
0.00%
0.00%
100.00%
90.23%
75.81%
80.54%
79.71%

Janux Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-5
-28
-20
-23
-33
-24
-31
-24
-21
-21
Operating Cash Flow
-10
-2
-16
-17
-23
-12
-28
-12
12
-25
Investing Cash Flow
-190
12
33
-340
1
8
29
8
-38
38
Financing Cash Flow
2
1
386
0
0
0
2
3
2
0
Change in Cash
-198
12
403
-356
-21
-4
3
0
-24
14

Janux Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-6
-32
-63
-58
-68
-113
Operating Cash Flow
-3
-4
-16
-42
-50
-43
-82
Investing Cash Flow
-
-
-340
58
-41
-258
-300
Financing Cash Flow
4
11
386
0
59
713
4
Change in Cash
0
7
28
15
-32
411
-378

Global Institutional Holdings in Janux Therapeutics Inc

Check out the Institutions with significant holdings in Janux Therapeutics Inc.

Funds
Holdings
Ra Capital Management, Llc
18.31%
Peter Kolchinsky
18.29%
BlackRock, Inc.
10.03%
iShares
4.50%
Vanguard
4.20%

Janux Therapeutics Inc News & Key Events

    Insights on Janux Therapeutics Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 4 quarters, -31.94M → -21.56M (in $), with an average increase of 14.6% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 834.0% return, outperforming this stock by 894.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Moderna, Inc. Common Stock has given 212.2% return, outperforming this stock by 174.2%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 10.26M → 9.28M (in $), with an average decrease of 9.5% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, JANX stock has moved down by -34.8%

    About Janux Therapeutics Inc

    Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to target specific antigens such as prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. In addition to its TRACTr pipeline, the company is also developing a Tumor Activated Immunomodulator (TRACIr) — a costimulatory bispecific candidate designed to enhance T cell anti-tumor activity by engaging with programmed death-ligand 1 and CD28. Furthermore, a specific focus for their EGFR-TRACTr program is addressing epidermal growth factor receptor, a target prevalent in many cancer types and already a focus of numerous approved monoclonal antibody treatments. Janux Therapeutics, Inc. was founded in 2017 and is headquartered in La Jolla, California.
    OrganisationJanux Therapeutics Inc
    Headquarters10955 Vista Sorrento Parkway, San Diego, CA, 92130, US
    IndustryBiotechnology
    CEODavid Alan Campbell

    Key Management of Janux Therapeutics Inc

    Name

    Title

    Ms. Janeen Doyle

    Chief Corporate & Business Development Officer

    Mr. Matt Whitmire

    Vice President of Finance

    Ms. Maria Dobek

    Vice President of Accounting

    Mr. James Pennington

    General Counsel & Corporate Secretary

    Ms. Mandie Forman-Sklansky

    Head of Human Resources

    Dr. David Alan Campbell Ph.D.

    President, Co-Founder, CEO & Director

    Dr. Thomas Diraimondo Ph.D.

    Chief Scientific Officer

    FAQs

    What is Janux Therapeutics Inc share price today?

    Janux Therapeutics Inc share price today is $11.36 as on at the close of the market. Janux Therapeutics Inc share today touched a day high of $11.56 and a low of $11.16.

    What is the 52 week high and 52 week low for Janux Therapeutics Inc share?

    Janux Therapeutics Inc share touched a 52 week high of $35.34 on and a 52 week low of $11.16 on . Janux Therapeutics Inc stock price today i.e. is closed at $11.36,which is 67.86% down from its 52 week high and 1.84% up from its 52 week low.

    What is Janux Therapeutics Inc's market capitalisation today?

    Janux Therapeutics Inc market capitalisation is $0.00T as on .

    How to invest in Janux Therapeutics Inc Stock (JANX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Janux Therapeutics Inc on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Janux Therapeutics Inc Stock (JANX) from India?

    Indian investors can start investing in Janux Therapeutics Inc (JANX) shares with as little as ₹94.2300033569336 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹942.30 in Janux Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Janux Therapeutics Inc share’s latest price of $11.36 as on November 14, 2026 at 2:29 am IST, you will get 0.8803 shares of Janux Therapeutics Inc. Learn more about fractional shares .

    What are the returns that Janux Therapeutics Inc has given to Indian investors in the last 5 years?

    Janux Therapeutics Inc stock has given -49.42% share price returns and 26.25% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?